BIOPLUS ACQUISITION CORP.

(BIOSU)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BioPlus Acquisition Corp. announced that it expects to receive $6.4 million in funding from Bioplus Sponsor LLC, Cantor Fitzgerald & Co, Investment Arm

06/21/2021 EDT

BioPlus Acquisition Corp. announced that it has entered into an agreement for private placement of 640,000 units at a purchase price of $10.00 per unit for gross proceeds of $6,400,000 on June 21, 2021. The transaction will include participation from returning investor Bioplus Sponsor LLC for 420,000 units and Cantor Fitzgerald & Co, Investment Arm for 220,000 units. Each unit consists of one Class A ordinary share and one- fourth of one warrant. Each warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation. Warrants may be exercised only for a whole number of shares. If any fractional interests would be issuable upon exercise of a placement warrant, we will round down to the nearest whole number the number of Class A ordinary shares to be issued to the holder. The placement units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of our initial business combination.


© S&P Capital IQ 2021
All news about BIOPLUS ACQUISITION CORP.
05/12BIOPLUS ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
05/12BioPlus Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31..
CI
03/11BIOPLUS ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition ..
AQ
03/11BioPlus Acquisition Corp. Reports Earnings Results for the Eleven Months Ended December..
CI
01/31BIOPLUS ACQUISITION CORP.(NASDAQGM : BIOS) added to NASDAQ Composite Index
CI
2021BIOPLUS ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021BIOPLUS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale ..
AQ
2021BioPlus Acquisition Corp. announced that it has received $10.6 million in funding from ..
CI
2021BioPlus Acquisition Corp. has completed an IPO in the amount of $200 million.
CI
2021BioPlus Acquisition Corp. has filed an IPO in the amount of $220 million.
CI
More news
Chart BIOPLUS ACQUISITION CORP.
Duration : Period :
BioPlus Acquisition Corp. Technical Analysis Chart | BIOSU | KYG112171098 | MarketScreener
Managers and Directors
Ross Haghighat Chief Executive & Financial Officer, Director
Jonathan M. N. Rigby Chairman & Chief Business Officer
Louis G. Lange Independent Director
Stephen A. Sherwin Independent Director
Glen Giovannetti Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIOPLUS ACQUISITION CORP.-0.60%290
INVESTOR AB (PUBL)-16.05%59 130
CK HUTCHISON HOLDINGS LIMITED11.23%27 332
GROUPE BRUXELLES LAMBERT SA-11.45%13 573
HAL TRUST-8.37%12 410
AB INDUSTRIVÄRDEN (PUBL)-10.30%11 298